Ma G, Brady W J, Pollack M, Chan T C
Department of Emergency Medicine, University of California San Diego Medical Center, 200 West Arbor Drive #8676, San Diego, CA 92130-8676, USA.
J Emerg Med. 2001 Feb;20(2):145-52. doi: 10.1016/s0736-4679(00)00312-7.
Toxicity from the digitalis family of cardiac glycoside medications remains common. Successful treatment depends on early recognition; however, the diagnosis of potentially life-threatening toxicity remains difficult because the clinical presentation is often nonspecific and subtle. The hallmark of cardiac toxicity is increased automaticity coupled with concomitant conduction delay. Though no single dysrhythmia is always present, certain aberrations such as frequent premature ventricular beats, bradydysrhythmias, paroxysmal atrial tachycardia with block, junctional tachycardia, and bidirectional ventricular tachycardia are common. Treatment depends on the clinical condition rather than serum drug level. Management varies from temporary withdrawal of the medication to administration of digoxin-specific Fab fragments for life-threatening cardiovascular compromise.
洋地黄类强心苷药物的毒性仍然很常见。成功的治疗取决于早期识别;然而,潜在危及生命的毒性诊断仍然困难,因为临床表现往往是非特异性的且很细微。心脏毒性的标志是自律性增加并伴有传导延迟。虽然并非总是出现单一的心律失常,但某些异常情况如频发室性早搏、缓慢性心律失常、伴有阻滞的阵发性房性心动过速、交界性心动过速和双向性室性心动过速很常见。治疗取决于临床状况而非血清药物水平。处理方法从暂时停用药物到给予地高辛特异性Fab片段以治疗危及生命的心血管功能损害不等。